The ONLY way to recover lost microbial diversity is
with a fecal microbiota transp...
Scientists are excited by recent success
with fecal microbiota transplants (FMT), transfer of healthy fecal matter into ailing patients, notably those with clostridium difficile (C. diff), a bacterial infection acquired after antibiotics, often in hospitals, that kills more than 15,000 people a year.
Probiotics / prebiotics / antibiotics Tacrolimus concentration to dose ratio in solid organ transplant patients treated
with fecal microbiota transplantation for recurrent Clostridium difficile infection.
Not exact matches
Prof. Severine Vermeire (KU Leuven / UZ Leuven): «In the future, gut bacteria may be used to help identify PSC patients
with a more or less aggressive disease, or patients that may benefit from
microbiota - based therapies, such as
fecal microbiota transplantation or targeted pre - and probiotics.»
A team led by gastroenterologists Sieglinde Angelberger and Walter Reinisch (Medical University Vienna) and microbiologists David Berry and Alexander Loy (University of Vienna) explored how a treatment called «
fecal microbiota transplantation» can be used to support microbial recolonization of the gut of patients
with chronic intestinal inflammation (ulcerative colitis).
«
Fecal microbiota transplantation has been very successful for many patients
with C. difficile infections, but we've never known why.
Separate groups of germfree mice were colonized
with uncultured
fecal microbiota from each member of four twin pairs discordant for obesity or
with culture collections from an obese (Ob) or lean (Ln) co-twin.
Using
fecal transplants, researchers transferred
microbiota from IBS patients
with or without anxiety into germ - free mice.
The goal of the study was to explore whether
fecal microbiota from human IBS patients
with diarrhea has the ability to influence gut and brain function in recipient mice.
Fecal microbiota transplantation induces remission in patients
with active ulcerative colitis in a randomized controlled trial.
Effect of Vegan
Fecal Microbiota Transplantation on Carnitine and Choline ‐ Derived Trimethylamine ‐ N ‐ Oxide Production and Vascular Inflammation in Patients
With Metabolic Syndrome — Loek P. Smits — Journal of the American Heart Association
Fecal microbiota transplantation in puppies
with canine parvovirus infection — Giorgio Q. Pereira — Journal of Veterinary Internal Medicine
Variations in gut
microbiota and
fecal metabolic phenotype associated
with Fenbendazole and Ivermectin Tablets by 16S rRNA gene sequencing and LC / MS - based metabolomics in Amur tiger — Fengping He — Biochemical and Biophysical Research Communications
Successful
Fecal Microbiota Transplantation in a Patient
with Severe Complicated Clostridium difficile Infection after Liver Transplantation
Comparative metaproteomics analysis shows altered
fecal microbiota signatures in patients
with major depressive disorder — Zhi Chen — NeuroReport
Fecal Microbiota Signatures Are Associated
with Response to Ustekinumab Therapy among Crohn's Disease Patients — Matthew K. Doherty — mBio
Fecal microbiota are a subset of the microorganisms present in the gastrointestinal tract that are shed during defecation, and as such give much information about an individual's core gut microbiome as well as allochthonous bacteria associated
with ingested food, water and very likely, air.
The first study of the social and ethical issues associated
with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called «
fecal microbiota transplantation» to become available, although many have concerns about donor selection, screening, and methods of delivery.
June 2, 2011 Patients
with bowel disease eager to test «
fecal» therapy The first study of the social and ethical issues associated
with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called «
fecal microbiota transplantation» to become available, although many have concerns about donor selection, screening, and methods of delivery.
Like an organ transplant,
fecal microbiota transplantation begins
with finding a donor, often a family member.
With antibiotics in particular, however, there is evidence of localized permanent extinction — in other words, some species of microorganisms never recover post-antibiotic, and can not be «reinoculated» unless you undergo the arduous and expensive process of
fecal microbiota transplant (FMT).
In this follow - up interview
with Glenn Taylor of the Taymount Clinic in the U.K., we discuss the latest developments in
fecal microbiota transplant (FMT).
Dr. Davis is one of a handful of physicians in North America
with clinical expertise in
fecal microbiota transplantation (FMT), which he offers via retention enema and capsule.
Molecular assessment of the
fecal microbiota in healthy cats and dogs before and during supplementation
with fructo - oligosaccharides (FOS) and inulin using high - throughput 454 - pyrosequencing